Publicaciones en colaboración con investigadoras/es de Hospital Vall d'Hebron (6)

2017

  1. Consenso sobre el manejo del cáncer de próstata resistente a la castración avanzado en España

    Archivos Espanoles de Urologia, Vol. 70, Núm. 9, pp. 777-791

2016

  1. Expert opinion on first-line therapy in the treatment of castration-resistant prostate cancer

    Critical Reviews in Oncology/Hematology, Vol. 100, pp. 127-136

2015

  1. Methodological aspects of the molecular and histological study of prostate cancer: Focus on PTEN

    Methods, Vol. 77, pp. 25-30

2013

  1. Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study

    British Journal of Cancer, Vol. 109, Núm. 1, pp. 121-130

  2. Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study

    British Journal of Cancer, Vol. 108, Núm. 12, pp. 2565-2572

2011

  1. Prostate cancer in Spain: From guidelines to clinical practice

    BJU International, Vol. 108, Núm. 1, pp. 61-66